{"transactions":[{"id":737581,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-06-16T01:30:05.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":40565,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":209331,"derivative":{"exercise_price":1.59,"exercise_date":"2027-06-11","expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":40565},"source":{"system":"sec-edgar","filing":"0001543174-26-000005","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000154317426000005/ownership.xml","form_type":"4"}},{"id":743711,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T01:09:17.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":4357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in full on May 21, 2027."}],"balance_after":29514,"source":{"system":"sec-edgar","filing":"0001543174-26-000003","document":"wk-form4_1781140154.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000154317426000003/wk-form4_1781140154.xml","form_type":"4"}},{"id":976646,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-09T23:09:45.000Z","date":"2025-12-05","kind":"sale","planned":false,"acquired":false,"shares":1800,"price":81.15,"value":146070.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple trades at prices ranging from $81.14 to $81.16. The price reported above reflects the weighted average sales price."}],"balance_after":25157,"source":{"system":"sec-edgar","filing":"0001543174-25-000006","document":"wk-form4_1765321783.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000154317425000006/wk-form4_1765321783.xml","form_type":"4"}},{"id":1099113,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-06-30T13:39:52.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":40565,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":168766,"derivative":{"exercise_price":3.16,"exercise_date":"2026-06-26","expiration_date":"2035-06-26","underlying":"Common Stock","underlying_shares":40565},"source":{"system":"sec-edgar","filing":"0001641172-25-017072","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000164117225017072/ownership.xml","form_type":"4"}},{"id":1134019,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-27T22:17:20.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":4336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in full on May 22, 2026."}],"balance_after":26957,"source":{"system":"sec-edgar","filing":"0001543174-25-000002","document":"wk-form4_1748384233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000154317425000002/wk-form4_1748384233.xml","form_type":"4"}},{"id":1330627,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-16T22:00:03.000Z","date":"2024-12-12","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.4224,"value":34224.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000950170-24-136725","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000095017024136725/ownership.xml","form_type":"4"}},{"id":1465596,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-07-01T20:09:21.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":29700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":128201,"derivative":{"exercise_price":2.33,"exercise_date":"2025-06-27","expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":29700},"source":{"system":"sec-edgar","filing":"0001628280-24-030642","document":"wk-form4_1719864555.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828024030642/wk-form4_1719864555.xml","form_type":"4"}},{"id":1504252,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-23T23:59:40.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":4410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in full on May 21, 2025."}],"balance_after":22621,"source":{"system":"sec-edgar","filing":"0001543174-24-000005","document":"wk-form4_1716508769.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000154317424000005/wk-form4_1716508769.xml","form_type":"4"}},{"id":1512279,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-17T22:01:01.000Z","date":"2024-05-16","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":63.87,"value":127740.0,"ownership":{"direct":true},"balance_after":18211,"source":{"system":"sec-edgar","filing":"0001543174-24-000002","document":"wk-form4_1715983230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000154317424000002/wk-form4_1715983230.xml","form_type":"4"}},{"id":1849146,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-06-20T21:02:40.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":27700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":98501,"derivative":{"exercise_price":1.59,"exercise_date":"2024-06-15","expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":27700},"source":{"system":"sec-edgar","filing":"0001628280-23-022731","document":"wk-form4_1687294950.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828023022731/wk-form4_1687294950.xml","form_type":"4"}},{"id":1880231,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-24T20:36:09.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":6865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in full on May 23, 2024."}],"balance_after":20211,"source":{"system":"sec-edgar","filing":"0001104659-23-064160","document":"tm2316872-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923064160/tm2316872-6_4seq1.xml","form_type":"4"}},{"id":2155393,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-19T12:37:44.000Z","date":"2022-09-15","kind":"purchase","acquired":true,"shares":3600,"price":1.72,"value":6192.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001628280-22-025101","document":"wf-form4_166359105093640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022025101/wf-form4_166359105093640.xml","form_type":"4"}},{"id":2155392,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-19T12:37:44.000Z","date":"2022-09-15","kind":"purchase","acquired":true,"shares":6400,"price":1.715,"value":10976.0,"ownership":{"direct":true},"balance_after":6400,"source":{"system":"sec-edgar","filing":"0001628280-22-025101","document":"wf-form4_166359105093640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022025101/wf-form4_166359105093640.xml","form_type":"4"}},{"id":2322097,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-22T21:36:25.000Z","date":"2022-03-19","kind":"grant","acquired":true,"shares":13346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in three equal annual installments on the first, second and third anniversaries of March 19, 2022."}],"balance_after":13346,"source":{"system":"sec-edgar","filing":"0001415889-22-003266","document":"form4-03222022_020316.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588922003266/form4-03222022_020316.xml","form_type":"4"}},{"id":2339543,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-03-10T23:43:11.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":26800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":70801,"derivative":{"exercise_price":2.5,"exercise_date":"2023-03-09","expiration_date":"2032-03-09","underlying":"Common Stock","underlying_shares":26800},"source":{"system":"sec-edgar","filing":"0001628280-22-005796","document":"wf-form4_164695577272689.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022005796/wf-form4_164695577272689.xml","form_type":"4"}},{"id":2341604,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-09T19:11:44.000Z","date":"2022-03-07","kind":"disposition_to_issuer","acquired":false,"shares":22000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"(Continued from Footnote 2) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":17.83,"expiration_date":"2031-05-26","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0000899243-22-010303","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924322010303/doc4.xml","form_type":"4"}},{"id":2341603,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-09T19:11:44.000Z","date":"2022-03-07","kind":"disposition_to_issuer","acquired":false,"shares":3000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"(Continued from Footnote 2) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":12.8,"expiration_date":"2025-06-17","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0000899243-22-010303","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924322010303/doc4.xml","form_type":"4"}},{"id":2341602,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-09T19:11:44.000Z","date":"2022-03-07","kind":"other","acquired":false,"shares":32567,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger, dated January 18, 2022, (the \"Merger Agreement\"), among UCB S.A., a societe anonyme formed under the laws of Belgium (\"Parent\"), Zinc Merger Sub, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent (\"Purchaser\") and the Issuer, pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of March 7, 2022 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was canceled and converted into the right to receive $26.00 in cash (the \"Cash Amount\") plus a contingent value right (\"CVR\"), which CVR represents the right to receive a contingent payment of $2.00 which amount will become payable, if at all, if a specified milestone is achieved on or prior to December 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger, dated January 18, 2022, (the \"Merger Agreement\"), among UCB S.A., a societe anonyme formed under the laws of Belgium (\"Parent\"), Zinc Merger Sub, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent (\"Purchaser\") and the Issuer, pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of March 7, 2022 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was canceled and converted into the right to receive $26.00 in cash (the \"Cash Amount\") plus a contingent value right (\"CVR\"), which CVR represents the right to receive a contingent payment of $2.00 which amount will become payable, if at all, if a specified milestone is achieved on or prior to December 31, 2023."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-010303","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924322010303/doc4.xml","form_type":"4"}},{"id":2491972,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-30T21:55:22.000Z","date":"2021-11-29","kind":"sale","acquired":false,"shares":5305,"price":11.72,"value":62174.6,"ownership":{"direct":true},"balance_after":32567,"source":{"system":"sec-edgar","filing":"0001375151-21-000102","document":"wf-form4_163832730682507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000102/wf-form4_163832730682507.xml","form_type":"4"}},{"id":2669862,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-06-14T20:13:36.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":44001,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"14,667 vest on 6/10/2022, 6/10/2023, and 6/20/2024"}],"balance_after":44001,"derivative":{"exercise_price":7.98,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":44001},"source":{"system":"sec-edgar","filing":"0001628280-21-012177","document":"wf-form4_162370159154248.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828021012177/wf-form4_162370159154248.xml","form_type":"4"}},{"id":2682925,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-03T19:20:57.000Z","date":"2021-06-01","kind":"purchase","acquired":true,"shares":5000,"price":17.0495,"value":85247.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.045 to $17.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":37872,"source":{"system":"sec-edgar","filing":"0001375151-21-000072","document":"wf-form4_162276242870509.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000072/wf-form4_162276242870509.xml","form_type":"4"}},{"id":2691042,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-28T19:59:41.000Z","date":"2021-05-27","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on May 27, 2021, the date of the Issuer's 2021 Annual Meeting of Stockholders, and shall become exercisable with respect to the underlying shares of common stock in a series of twelve (12) successive, equal monthly installments on each monthly anniversary of the grant date, such that the option shall be fully vested twelve months following the date of grant, subject to the Reporting Person's continuing service on the Board of the Issuer through such dates."}],"balance_after":22000,"derivative":{"exercise_price":17.83,"expiration_date":"2031-05-27","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001375151-21-000058","document":"wf-form4_162224636664484.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000058/wf-form4_162224636664484.xml","form_type":"4"}},{"id":2974926,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-18T17:05:48.000Z","date":"2020-11-17","kind":"sale","acquired":false,"shares":15000,"price":20.7377,"value":311065.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected to satisfy certain tax obligations of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.69 to $20.80, inclusive. The Reporting Person undertakes to provide to Zogenix, Inc., any security holder of Zogenix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":32872,"source":{"system":"sec-edgar","filing":"0001375151-20-000155","document":"wf-form4_160573713523913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000155/wf-form4_160573713523913.xml","form_type":"4"}},{"id":3097472,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-29T21:12:04.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on May 29, 2020, the date of the Company's 2020 Annual Meeting of Stockholders, and vests in twelve (12) equal monthly installments from the grant date, such that the option is fully vested on the one-year anniversary of the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date."}],"balance_after":13000,"derivative":{"exercise_price":29.13,"expiration_date":"2030-05-29","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001375151-20-000110","document":"wf-form4_159347950820430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000110/wf-form4_159347950820430.xml","form_type":"4"}},{"id":3510154,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-28T16:07:08.000Z","date":"2019-05-22","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on May 22, 2019, the date of the Company's 2019 Annual Meeting of Stockholders, and vests in twelve (12) equal monthly installments from the grant date, such that the option is fully vested on the one-year anniversary of the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date."}],"balance_after":13000,"derivative":{"exercise_price":39.02,"expiration_date":"2029-05-22","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001375151-19-000081","document":"wf-form4_155907401375516.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515119000081/wf-form4_155907401375516.xml","form_type":"4"}},{"id":3603919,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-08T16:48:23.000Z","date":"2019-03-06","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was granted on May 23, 2017, the date of the Company's Annual Meeting of Stockholders, and vests in a series of twelve (12) successive, equal monthly installments measured from the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":12.75,"expiration_date":"2027-05-22","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001375151-19-000024","document":"wf-form4_155208168912225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515119000024/wf-form4_155208168912225.xml","form_type":"4"}},{"id":3603918,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-08T16:48:23.000Z","date":"2019-03-06","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was granted on July 13, 2016 and vests in a series of twelve (12) successive, equal monthly installments, on the first day of each calendar month following the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":8.99,"expiration_date":"2026-07-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001375151-19-000024","document":"wf-form4_155208168912225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515119000024/wf-form4_155208168912225.xml","form_type":"4"}},{"id":3603917,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-08T16:48:23.000Z","date":"2019-03-06","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on June 18, 2015 and vests in a series of twelve (12) successive, equal monthly installments measured from the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date."}],"balance_after":3000,"derivative":{"exercise_price":12.8,"expiration_date":"2025-06-17","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001375151-19-000024","document":"wf-form4_155208168912225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515119000024/wf-form4_155208168912225.xml","form_type":"4"}},{"id":3603916,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-08T16:48:23.000Z","date":"2019-03-06","kind":"exercise","acquired":false,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on February 6, 2015, which is the vesting commencement date. Shares subject to the option vests over three years in thirty-six equal monthly installments, subject to the Reporting Person's continued service to the Company on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.4,"expiration_date":"2025-02-05","underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001375151-19-000024","document":"wf-form4_155208168912225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515119000024/wf-form4_155208168912225.xml","form_type":"4"}},{"id":3603915,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-08T16:48:23.000Z","date":"2019-03-06","kind":"sale","acquired":false,"shares":17503,"price":50.647,"value":886474.441,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.These shares were sold in multiple transactions at prices ranging from $50.40 to $50.90, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":47872,"source":{"system":"sec-edgar","filing":"0001375151-19-000024","document":"wf-form4_155208168912225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515119000024/wf-form4_155208168912225.xml","form_type":"4"}},{"id":3603914,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-08T16:48:23.000Z","date":"2019-03-06","kind":"exercise","acquired":true,"shares":20000,"price":8.99,"value":179800.0,"ownership":{"direct":true},"balance_after":65375,"source":{"system":"sec-edgar","filing":"0001375151-19-000024","document":"wf-form4_155208168912225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515119000024/wf-form4_155208168912225.xml","form_type":"4"}},{"id":3603913,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-08T16:48:23.000Z","date":"2019-03-06","kind":"exercise","acquired":true,"shares":20000,"price":12.75,"value":255000.0,"ownership":{"direct":true},"balance_after":45375,"source":{"system":"sec-edgar","filing":"0001375151-19-000024","document":"wf-form4_155208168912225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515119000024/wf-form4_155208168912225.xml","form_type":"4"}},{"id":3603912,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-08T16:48:23.000Z","date":"2019-03-06","kind":"exercise","acquired":true,"shares":6000,"price":12.8,"value":76800.0,"ownership":{"direct":true},"balance_after":25375,"source":{"system":"sec-edgar","filing":"0001375151-19-000024","document":"wf-form4_155208168912225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515119000024/wf-form4_155208168912225.xml","form_type":"4"}},{"id":3603911,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-08T16:48:23.000Z","date":"2019-03-06","kind":"exercise","acquired":true,"shares":9375,"price":10.4,"value":97500.0,"ownership":{"direct":true},"balance_after":19375,"source":{"system":"sec-edgar","filing":"0001375151-19-000024","document":"wf-form4_155208168912225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515119000024/wf-form4_155208168912225.xml","form_type":"4"}},{"id":3918480,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-24T18:36:45.000Z","date":"2018-05-23","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Annual director stock option grant under the issuer's incentive compensation plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on May 23, 2018, the date of the Company's Annual Meeting of Stockholders, and vests in twelve (12) equal monthly installments from the grant date such that the option is fully vested on the one-year anniversary of the date of grant, subject to the reporting person's continued service to the Company on each vesting date."}],"balance_after":15000,"derivative":{"exercise_price":41.68,"expiration_date":"2028-05-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001375151-18-000047","document":"wf-form4_152720139166432.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515118000047/wf-form4_152720139166432.xml","form_type":"4"}},{"id":4307982,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-23T19:03:24.000Z","date":"2017-05-23","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Annual director stock option grant under the issuer's incentive compensation plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on May 23, 2017, the date of the Company's Annual Meeting of Stockholders, and vests in a series of twelve (12) successive, equal monthly installments beginning on June 23, 2017, subject to the reporting person's continued service to the Company on each vesting date."}],"balance_after":20000,"derivative":{"exercise_price":12.75,"expiration_date":"2027-05-22","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001375151-17-000039","document":"wf-form4_149558058929011.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515117000039/wf-form4_149558058929011.xml","form_type":"4"}},{"id":4377680,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-20T18:25:40.000Z","date":"2017-03-16","kind":"purchase","acquired":true,"shares":5000,"price":11,"value":55000.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000899243-17-008223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924317008223/doc4.xml","form_type":"4"}}]}